• Company
• Korean new drug cash cows bring in KRW 100 bil in 3 quarters
• by Chon, Seung-Hyun Oct 19, 2023 05:29am

• Company
• Global 1 trillion won project
• by Kim, Jin-Gu Oct 19, 2023 05:29am

• Policy
• NA calls for prompt reimb of Ilaris during NA audit
• by Lee, Tak-Sun Oct 19, 2023 05:29am

• Policy
• Rep. Young-hee Choi ‘expenses surged after Moon Care’
• by Lee, Tak-Sun Oct 18, 2023 05:49am

• Company
• Drug exports reduced by 14%... COVID-19 effect vanished
• by Kim, Jin-Gu Oct 18, 2023 05:48am

• Policy
• Layla+Celecoxib coming soon
• by Lee, Tak-Sun Oct 18, 2023 05:48am

• Policy
• Pharma-Bio Control Tower launched…first meeting next month
• by Lee, Jeong-Hwan Oct 18, 2023 05:48am

• Company
• Controversy arises over illegal rebates made by Company A
• by Nho, Byung Chul Oct 17, 2023 05:28am

• Policy
• Daewoong's new diabetes drug 'Envlo',
• by Lee, Tak-Sun Oct 17, 2023 05:28am

• Company
• 'Verquvo is effective in high-risk heart failure patients'
• by Son, Hyung-Min Oct 17, 2023 05:28am